COAG
Hemab Therapeutics Holdings, Inc.
Set alert
41.45 USD +1.03 +2.55%
39.38 Day range 42.85
24.98 52-week range 54.94
- YTD
- +21.91%
- 1 year
- +21.91%
- Open
- 40.34
- Prev close
- 40.42
- Mkt cap
- 1.94B
- Vol
- 765.62K
- Avg vol
- 454.15K
- EPS
- -4.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 39.38
- High
- 42.85
- Forward P/E
- -16.20
- Beta
- 0.00
- Short ratio
- 5.27
- Inst. own
- 92.50%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 10, 2026
- 50-d avg
- 38.04
- 200-d avg
- 36.74
- 1y target
- 62.67
Financial health
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -14.6×
FY 2025 5y median -14.6× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -5.3×
FY 2025 5y median -5.3× FY 2025
P/FCF -15.2×
FY 2025 5y median -15.2× FY 2025
EV/EBITDA -12.1×
FY 2025 5y median -12.1× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -6.6%
FY 2025 5y median -6.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 36.2%
FY 2025 5y median 36.2% FY 2025
ROIC -37.8%
FY 2025 5y median -37.8% FY 2025
ROA -32.8%
FY 2025 5y median -32.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 18.0×
FY 2025 5y median 18.0× FY 2025
Quick Ratio 18.0×
FY 2025 5y median 18.0× FY 2025
Debt / Equity -0.0×
FY 2025 5y median -0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2025 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31